Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

FDA expands J&J Zytiga combo’s indication to include castration-sensitive prostate cancer

February 9, 2018 Medical Communications, Sales and Marketing Cancer, FDA, J&J, JJ, Janssen, Johnson & Johnson, Zytiga, pharma

Johnson & Johnson has announced that Zytiga (abiraterone acetate) in combination with prednisone has been awarded FDA approval in the …
News
teva_copy

Migraine drug bad news hits a weakened Teva

February 9, 2018 Medical Communications, Sales and Marketing CGRP, Teva, biotech, drugs, pharma, pharmaceutical

The cacophony of bad news that Teva has received in 2017 really needs no retelling, anyone following the story of …
News
peter_goldschmidt_web

Stada poaches Novartis exec for fifth CEO in two years

February 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Stada, appointment

Stada has revealed its new CEO as Peter Goldschmidt, the current head of North American operations at Novartis’ generics and …
Appointment
bob_hugin1

Celgene Executive Chairman Bob Hugin retires

February 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Fresh from its acquisition of Juno Therapeutics, Celgene announced that its Executive Chairman Bob Hugin was to retire effective 5 …
Appointment
online_feature_image

New Year, new goals

February 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer Research UK, Chiesi, EMA, FDA, Genetic Alliance, pharma

With the New Year begun in earnest, Pharmafocus speaks to a range of players in pharma and the life sciences …
Feature
facilities_lg06

Dr Reddy’s hit by yet another recall, of 80,000+ bottles

February 8, 2018 Sales and Marketing Dr Reddy's, FDA, biotech, drugs, pharma, pharmaceutical

Dr Reddy’s Laboratories problem with ensuring products reach the market at a quality the FDA deems acceptable is no secret …
News
gilead-sciences

FDA approves Gilead’s Biktarvy for HIV as Viiv Healthcare launches patent lawsuit

February 8, 2018 Sales and Marketing Biktarvy, FDA, GSK, Gilead, HIV, Pfizer, Shionogi, US, ViiV Healthcare, descovy, pharma

Gilead has announced that its daily single-tablet therapy Biktarvy has received FDA approval for HIV-1 infection.
News
novartis_window

Novartis tastes own medicine, Advair generic delayed

February 8, 2018 Sales and Marketing FDA, Novartis, biotech, drugs, pharma, pharmaceutical

Novartis had not been frontrunner to receive approval for its generic version of GSK’s Advair – lagging behind Mylan’s generic …
News

Theravance seals potential $1bn deal with J&J

February 8, 2018 Sales and Marketing Johnson & Johnson, Theravance Biopharma, biotech, drugs, pharma, pharmaceutical

The JAK inhibitor field is beginning to heat up – AbbVie is soon to enter Phase 3 with its predicted …
News
kenji

Astellas confirms Kenji Yasukawa as new President and CEO

February 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, appointment

Japanese pharmaceutical firm Astellas has announced that its Board of Directors has approved the selection of current Chief Strategy Officer …
Appointment
arcturus_joseph-e-payne

CEO gets the axe: Arcturus relieve Payne of position

February 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Arcturus, biotech, drugs, pharma, pharmaceutical

Early in February, Arcturus Therapeutics revealed that it had let its CEO, Joseph Payne, go and had replaced him as …
Appointment
allergan

Allergan bolsters skincare portfolio with Elastagen acquisition for $95 million

February 7, 2018 Research and Development, Sales and Marketing Allergan, Elastagen, M&A, MA, pharma

Pharma’s M&A train keeps on going as news breaks that Allergan has picked up University of Sydney spin-off Elastagen for …
News
mark_walsh_allergan

Allergan successfully concludes CFO search

February 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical

Allergan has been searching for a new Chief Financial Officer since Tessa Hilado, its current CFO, revealed that she would …
Appointment
radio-active-2003201_960_720

PTx picks up radiation drug and plant from Sanofi

February 6, 2018 Manufacturing and Production, Sales and Marketing Partnership Therapeutics, Sanofi, biotech, drugs, pharma, pharmaceutical

A Boston-based biotech, only a few weeks old, has moved quickly to secure both the drug Leukine and the plant …
News
ai_graphic

The future is now: The transformative power of AI

February 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Exscientia, GSK, GlaxoSmithKline, artificial intelligence, drug development, pharma

With the technologies reaching exciting levels of maturity and adoption, Matt Fellows investigates how AI and machine learning can be …
Feature
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026